glp 1 gip combo Why does GLP‐1 agonist combined with and/or GCG agonist have greater weight loss effect than GLP‐1 agonist alone in obese adults without type 2 diabetes? - Jiang - 2025 Highlights the relevant functions of
Description
If tirzepatide alone is insufficient, combination with a different class of medication, like phentermine or metformin, is a more logical approach
Moreover, recent international guidelines recommend extending surgical eligibility to patients with BMI 30 kg/m 2 with comorbidities and even 27.5 kg/m 2 in Asian populations with poorly controlled diabetes [24]
Well-powered, controlled trials are needed to confirm efficacy and safety, identify optimal subgroups, and evaluate long-term outcomes
The majority of preclinical evidence is derived from rodent models that often represent acute or subacute disease states
